Patients and web;Les patients et internet

Bulletin du Cancer

Volumn 97, Issue 10, 2010, Pages 1133-1136

  Cluzeau, T ^a   Mounier, N ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Cancer; HIV; Hodgkin disease; Interne

Indexed keywords

ANTIRETROVIRUS AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTOCHROME P450; DACARBAZINE; DOXORUBICIN; EPSTEIN BARR VIRUS ANTIGEN 1; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NAVELBINE; PREDNISONE; PROCARBAZINE; VINCRISTINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION RETRIEVAL; INTERNET; MALIGNANT NEOPLASTIC DISEASE; MEDICAL INFORMATION; MEDICAL LITERATURE; PUBLICATION; REVIEW; ARTICLE; B CELL LYMPHOMA; DRUG COMBINATION; EVALUATION; INFORMATION DISSEMINATION; MEDICAL INFORMATICS; METHODOLOGY; MORTALITY; PATIENT EDUCATION; PROGNOSIS; STANDARD;

ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HUMANS; INFORMATION DISSEMINATION; INTERNET; LYMPHOMA, AIDS-RELATED; MEDICAL INFORMATICS APPLICATIONS; PATIENT EDUCATION AS TOPIC; PROGNOSIS;

EID: 78049258424     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1160     Document Type: Review

References (14)

1. Hartzband P, Groopman J. Untangling the Web - patients, doctors and Internet. N Engl J Med 2010 ; 362 : 1063-6.
2. Rapezzi D, Ugolini D, Ferraris AM, Racchi O, Gaetani GF. Histological subtypes of Hodgkin's disease in the setting of HIV infection. Ann Hematol 2001 ; 80 : 340-4. (Pubitemid 32591084)
3. Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003 ; 21 : 3447-53.
4. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. Aids 2006 ; 20 : 1645-54.
5. Herndier BG, Sanchez HC, Chang KL, Chen YY, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol 1993 ; 142 : 1073-9.
6. Tirelli U, Serraino D, Spina M, Carbone A. Epstein-Barr virus-encoded latent membrane protein-1 expression as prognostic factor in AIDS-related non-Hodgkin's lymphoma. Aids 1995 ; 9 : 99-100.
7. Dolcetti R, Boiocchi M, Gloghini A, Carbone A. Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease. Eur J Cancer 2001 ; 37 : 1276-87.
8. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/ AIDS. Blood 2006 ; 108 : 3786-91. (Pubitemid 44864560)
9. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998 ; 339 : 1506-14.
10. Hoffmann C, Chow KU, Wolf E, Faetkenheuer G, Stellbrink HJ, van Luzen J, et al. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol 2004 ; 125 : 455-62.
11. Xicoy B, Ribera JM, Miralles P, Berenguer J, Rubio R, Mahillo B, et al. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma. Haematologica 2007 ; 92 : 191-8.
12. Spina M, Gabarre J, Rossi G, Fasan M, Schiantarelli C, Nigra E, et al. STANFORD V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood 2002 ; 100 : 1984-8.
13. Hartmann P, Rehwald U, Salzberger B, Franzen C, Sieber M, Wohrmann A, et al. BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection. Ann Oncol 2003 ; 14 : 1562-9. (Pubitemid 37304614)
14. Mounier N, Katlama C, Costagliola D, Chichmanian RM, Spano JP. Drug interactions between antineoplastic and antiretroviral therapies: implications and management for clinical practice. Crit Rev Oncol Hematol 2008.